Nao Medical

Nao Medical's Astoria location in Queens, New York is a REMS-certified facility offering FDA-approved Spravato (esketamine) for eligible adults with treatment-resistant depression and for certain adults with major depressive disorder and acute suicidal ideation. Esketamine targets glutamate rather than serotonin or norepinephrine, working differently than conventional antidepressants.

Care includes clinical evaluation, benefits verification, prior authorization support, monitored in-office dosing with a post-dose observation period, and transportation planning for treatment days, with a dedicated care manager assigned to each eligible patient.

The Astoria clinic is one of several active Queens access points, accepting major insurance plans including Medicaid, Medicare, and commercial coverage, with benefits verified before treatment starts.